Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Shares Issued (2016 - 2024)

Iradimed (IRMD) has disclosed Shares Issued for 10 consecutive years, with $26322.0 as the latest value for Q4 2024.

  • On a quarterly basis, Shares Issued fell 84.46% to $26322.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $195727.0, a 19.84% decrease, with the full-year FY2024 number at $29618.0, down 83.24% from a year prior.
  • Shares Issued was $26322.0 for Q4 2024 at Iradimed, down from $169403.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $931732.0 in Q3 2020 to a low of $1.0 in Q2 2022.
  • A 5-year average of $192028.4 and a median of $67434.0 in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: crashed 100.0% in 2022, then skyrocketed 16940200.0% in 2023.
  • Iradimed's Shares Issued stood at $931732.0 in 2020, then crashed by 42.3% to $537627.0 in 2021, then plummeted by 100.0% to $1.0 in 2022, then surged by 16940200.0% to $169403.0 in 2023, then plummeted by 84.46% to $26322.0 in 2024.
  • Per Business Quant, the three most recent readings for IRMD's Shares Issued are $26322.0 (Q4 2024), $169403.0 (Q4 2023), and $2.0 (Q3 2023).